Yunyu Mao Clinical Center of Biotherapy at Zhongshan Hospital Fudan University Biography Publications Institution JoVE Articles Yunyu Mao has not added a biography. If you are Yunyu Mao and would like to personalize this page please email our Author Liaison for assistance. Publications Efficacy and Safety of Novel Multifunctional M10 CAR-T Cells in HIV-1-infected Patients: a Phase I, Multicenter, Single-arm, Open-label Study Cell Discovery. May, 2024 | Pubmed ID: 38740803 Current Status and Future Development of Anti-HIV Chimeric Antigen Receptor T-cell Therapy Immunotherapy. Feb, 2021 | Pubmed ID: 33225803 PD-L1 Chimeric Costimulatory Receptor Improves the Efficacy of CAR-T Cells for PD-L1-positive Solid Tumors and Reduces Toxicity in Vivo Biomarker Research. Nov, 2020 | Pubmed ID: 33292688 Engineering T Cells with Hypoxia-inducible Chimeric Antigen Receptor (HiCAR) for Selective Tumor Killing Biomarker Research. Oct, 2020 | Pubmed ID: 33292642 Author Spotlight: Advancements in Hypoxia-Sensitive CAR-T Therapy for Enhanced Cancer Immunotherapy Ying Xue*1, Yunyu Mao*2, Qibin Liao3, Chen Zhao4, Xiaoyan Zhang1,2,4, Jianqing Xu1,2,4 1Institutes of Biomedical Sciences, Fudan University, 2Clinical Center of Biotherapy at Zhongshan Hospital, Fudan University, 3Department of Oncology and Bio-therapeutic Center, Shenzhen Third People's Hospital, Southern University of Science and Technology, 4Shanghai Public Health Clinical Center, Fudan University JoVE 66697 Cancer Research
Author Spotlight: Advancements in Hypoxia-Sensitive CAR-T Therapy for Enhanced Cancer Immunotherapy Ying Xue*1, Yunyu Mao*2, Qibin Liao3, Chen Zhao4, Xiaoyan Zhang1,2,4, Jianqing Xu1,2,4 1Institutes of Biomedical Sciences, Fudan University, 2Clinical Center of Biotherapy at Zhongshan Hospital, Fudan University, 3Department of Oncology and Bio-therapeutic Center, Shenzhen Third People's Hospital, Southern University of Science and Technology, 4Shanghai Public Health Clinical Center, Fudan University JoVE 66697 Cancer Research